Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie de Guibert

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Haematologica|March 15, 2006
Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphomaSophie de Guibert, Arnaud Jaccard, Marc Bernard, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineagesFrédéric Gros, Yasmine Sebti, Sophie de Guibert, et al.
International Journal of Gastrointestinal Cancer|February 22, 2005
New drugs for colorectal cancer (irinotecan, oxaliplatin, raltitrexed) meet expectations in routine practice: a single center's experience before and after their introductionJoëlle Egreteau, Eveline Boucher, Sophie de Guibert, et al.
Bulletin Du Cancer|December 20, 2012
[Conventional therapeutic strategies for relapsed chronic lymphocytic leukemia]Romain Guièze, Loïc Ysebaert, Sophie de Guibert, et al.
Blood Advances|March 19, 2024
Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicityMatteo Mauget, Sophie Lemercier, Quentin Quelven, et al.
British Journal of Haematology|June 27, 2007
Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disordersYasmine Sebti, Amélie Le Maux, Frédéric Gros, et al.
European Journal of Immunology|October 16, 2004
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expressionBrigitte Birebent, Richard Lorho, Hélène Lechartier, et al.
Medicine|January 9, 2015
Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literatureElodie Meppiel, Isabelle Crassard, Régis Peffault de Latour, et al.
Ejhaem|September 29, 2025
<i>NOTCH1</i> Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective StudyClémence Haméon, Roch Houot, Emmanuel Gyan, et al.
Haematologica|January 2, 2008
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's diseaseCatherine Ansquer, Thomas Hervouët, Anne Devillers, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Haematologica|March 15, 2006
Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphomaSophie de Guibert, Arnaud Jaccard, Marc Bernard, et al.
Neoplasia (New York, N.Y.)|April 14, 2006
Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineagesFrédéric Gros, Yasmine Sebti, Sophie de Guibert, et al.
International Journal of Gastrointestinal Cancer|February 22, 2005
New drugs for colorectal cancer (irinotecan, oxaliplatin, raltitrexed) meet expectations in routine practice: a single center's experience before and after their introductionJoëlle Egreteau, Eveline Boucher, Sophie de Guibert, et al.
Bulletin Du Cancer|December 20, 2012
[Conventional therapeutic strategies for relapsed chronic lymphocytic leukemia]Romain Guièze, Loïc Ysebaert, Sophie de Guibert, et al.
Blood Advances|March 19, 2024
Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicityMatteo Mauget, Sophie Lemercier, Quentin Quelven, et al.
British Journal of Haematology|June 27, 2007
Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disordersYasmine Sebti, Amélie Le Maux, Frédéric Gros, et al.
European Journal of Immunology|October 16, 2004
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expressionBrigitte Birebent, Richard Lorho, Hélène Lechartier, et al.
Medicine|January 9, 2015
Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literatureElodie Meppiel, Isabelle Crassard, Régis Peffault de Latour, et al.
Ejhaem|September 29, 2025
<i>NOTCH1</i> Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective StudyClémence Haméon, Roch Houot, Emmanuel Gyan, et al.
Haematologica|January 2, 2008
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's diseaseCatherine Ansquer, Thomas Hervouët, Anne Devillers, et al.
Pageof 4